Antisense Therapeutics (ASX:ANP) receives first approval for phase two DMD clinical trial
Antisense Therapeutics (ASX:ANP) has received approval to conduct its phase two trial in non-ambulant boys with DMD in Turkey.
Source: themarketherald.com.au
Haluk Topalo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Haluk Topalo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Haluk Topalo Today - Breaking & Trending Today